Voclosporin: a novel calcineurin inhibitor with no impact on mycophenolic acid levels in patients with SLE

por van Gelder, Teun, Huizinga, Robert B, Lisk, Laura, Solomons, Neil
Publicado 2021

Identification of clinical and serological factors during induction treatment of lupus nephritis that are associated with renal outcome

por Dall'Era, Maria, Levesque, Victoria, Solomons, Neil, Truman, Matt, Wofsy, David
Publicado 2015

Predictors of treatment response in a lupus nephritis population: lessons from the Aspreva Lupus Management Study (ALMS) trial

por McDonald, Stephen, Yiu, Sean, Su, Li, Gordon, Caroline, Truman, Matt, Lisk, Laura, Solomons, Neil, Bruce, Ian N
Publicado 2022

Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study

por Isenberg, David, Appel, Gerald B., Contreras, Gabriel, Dooley, Mary A., Ginzler, Ellen M., Jayne, David, Sánchez-Guerrero, Jorge, Wofsy, David, Yu, Xueqing, Solomons, Neil
Publicado 2010

Creatinine Fluctuation in Patients With Lupus Nephritis: Considerations for Clinical Trial Endpoints

por Almaani, Salem, Bhatt, Udayan, Arriens, Cristina, Bonfa, Eloisa, Dall’Era, Maria, Houssiau, Frederic, Kalunian, Kenneth, Mackay, Megan, Sanchez-Guerrero, Jorge, Solomons, Neil, Rovin, Brad H.
Publicado 2020